scutellarin has been researched along with Diabetes Mellitus, Type 2 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, SQ; Liu, JY | 1 |
| Aini, M; Cai, R; Gao, Z; Huo, Y; Mijiti, A; Qie, R; Wang, Z | 1 |
| Fan, X; Li, S; Li, Z; Su, Y; Tian, M | 1 |
| Li, Y; Long, L; Lu, X; Luo, C; Wang, J; Xu, Y; Zheng, S | 1 |
| Chen, L; Deng, DY; Huang, P; Long, L; Luo, J; Tan, J; Wang, J; Yang, L; Zhang, LM; Zhou, W; Zhu, B | 1 |
5 other study(ies) available for scutellarin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Effect of breviscapine on urinary micro-albumine in patients with diabetes mellitus type 2].
Topics: Aged; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drugs, Chinese Herbal; Female; Flavonoids; Humans; Male; Middle Aged; Phytotherapy | 2003 |
Scutellarin alleviates type 2 diabetes (HFD/low dose STZ)-induced cardiac injury through modulation of oxidative stress, inflammation, apoptosis and fibrosis in mice.
Topics: Animals; Apigenin; Apoptosis; Biomarkers; Blood Glucose; Body Weight; Cardiovascular Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucuronates; Heart Diseases; Inflammation; Lipids; Male; Mice; Oxidative Stress; RNA, Messenger | 2021 |
Scutellarin Improves Type 2 Diabetic Cardiomyopathy by Regulating Cardiomyocyte Autophagy and Apoptosis.
Topics: Apigenin; Apoptosis; Autophagy; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Glucuronates; Humans; Myocytes, Cardiac; RNA, Messenger | 2022 |
Protective effects of scutellarin on type II diabetes mellitus-induced testicular damages related to reactive oxygen species/Bcl-2/Bax and reactive oxygen species/microcirculation/staving pathway in diabetic rat.
Topics: Animals; Apigenin; Apoptosis; bcl-2-Associated X Protein; Blood Vessels; Body Weight; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Glucuronates; Hyperglycemia; Immunohistochemistry; In Situ Nick-End Labeling; Male; Microcirculation; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Streptozocin; Testis; Ultrasonography, Doppler; Vascular Endothelial Growth Factor A | 2015 |
Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
Topics: Administration, Oral; Animals; Apigenin; Biological Availability; Caco-2 Cells; Chitosan; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Drug Carriers; Drugs, Chinese Herbal; Erigeron; Glucuronates; Humans; Male; Nanoparticles; Rats, Sprague-Dawley; Retinal Vessels; Vascular Endothelial Growth Factor A; Vitamin B 12; Zebrafish | 2017 |